Continued focused execution of RLY-2608 clinical trials in PI3Kα-mutated breast cancer and vascular malformations Appointed Lonnel Coats and Habib Dable, former biotech CEOs with launch and commercialization expertise, to the Company’s Board of Directors Approximately $596 million in cash, cash equivalents and investments at end of Q3 2025 CAMBRIDGE, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potent ...

AUSTIN, Texas, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Open Lending Corporation (Nasdaq: LPRO) (the “Company” or “Open Lending”), a leading provider of lending enablement and risk analytics solutions for financial institutions, today reported financial results for its third quarter ended September 30, 2025. “Our results reflect the strategic implementation of enhanced underwriting standards and a more conservative booking approach that we believe will reduce volatility in our profit share unit economics,” said Je ...

VERO BEACH, Fla., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Bimini Capital Management, Inc. (OTCQB:BMNM) ("Bimini” or the “Company”) today announced that Frank E. Jaumot has resigned as a director of the Company. Mr. Jaumot has been associated with the Company in various capacities dating back to its initial capital raise and has served as a director since 2009. Chairman and CEO Robert E. Cauley stated, “We are tremendously thankful for the many contributions Frank has made to Bimini since our earliest days and wis ...

EL SEGUNDO, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- A-Mark Precious Metals, Inc. (NASDAQ: AMRK), a leading fully integrated precious metals platform, reported results for the fiscal first quarter ended September 30, 2025. The Company also announced a definitive agreement to acquire all of the outstanding equity of Monex Deposit Company and certain related entities (Monex), one of the largest and most established direct-to-consumer (DTC) precious metals dealers in the U.S. Monex Acquisition Monex is a lead ...

Delivered Total and Net Investment Income of $36.7 million and $15.7 million, Respectively Investment Portfolio of $0.9 billion Conference Call Today, Thursday, November 6, 2025 at 6:00 p.m. ET MENLO PARK, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Runway Growth Finance Corp. (Nasdaq: RWAY) (“Runway Growth” or the “Company”), a leading provider of flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity, today announced its financial results for the third quarte ...

Record first quarter Revenue, Adjusted EBITDA, EPS, Adjusted EPS, and Free Cash FlowRevenue grew 16.5% versus prior year quarterEPS grew 91% year-over-year to $0.82 and adjusted EPS grew 74% to $0.90Raises Fiscal Year Guidance WASHINGTON, Nov. 06, 2025 (GLOBE NEWSWIRE) -- IBEX Limited (“ibex”) (Nasdaq: IBEX), a leading provider in global business process outsourcing and end-to-end customer engagement technology solutions, today announced financial results for its first fiscal quarter ended September 30, 202 ...

PLEASANTON, Calif., Nov. 6, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the third quarter ended September 30, 2025. Accessibility StatementSkip Navigation 10x Genomics expects fourth quarter 2025 revenue to be in the range of $154 million to $158 million, representing a 6% decline from the corresponding prior year period and 5% growth sequentially at the midpoint. Recent Updates "Our team delivered a solid third qu ...

Announces Issuance of $30.0 million Convertible Senior Unsecured Notes due 2031 Announces Amendment to Existing Credit Agreement LITTLE ROCK, Ark., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Westrock Coffee Company (Nasdaq: WEST) (“Westrock Coffee” or the “Company”) today reported financial results for the third quarter ended September 30, 2025. Third Quarter Highlights1 Consolidated Results Net sales were $354.8 million, an increase of 60.7%Gross profit was $41.4 million, an increase of 11.6% compared to the prior ...

Data rich period continues to support certepetide’s broad applicability and effectiveness Catalent enters into global license agreement for the use of certepetide as part of their SMARTag® Antibody-Drug Conjugate Technology Platform Strategic Alliance formed with GATC Health to exploit their Multiomics Advanced Technology™ artificial intelligence drug discovery platform Cash runway extended into the first quarter of 2027 with no debt Conference call scheduled for today at 4:30 p.m. Eastern Time BASKING RIDG ...

The company extends presence within key vertical markets, forging new strategic partnerships that strengthen AI leadership through its Agentic+ framework SANTA CLARA, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- SoundHound AI, Inc. (Nasdaq: SOUN), a global leader in voice and conversational AI, today reported its financial results for the third quarter 2025. “Enterprise AI adoption is booming globally, and SoundHound is strengthening its leading position with deployments in millions of end points across highly ...